Asr Vermogensbeheer N.V. Bristol Myers Squibb CO Call Options Transaction History
Asr Vermogensbeheer N.V.
- $8.24 Trillion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMY
# of Institutions
2,667Shares Held
1.62BCall Options Held
22.2MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA196MShares$9.55 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.62 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.2 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.56 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...